@article{oai:soar-ir.repo.nii.ac.jp:00021732,
 author = {Sano, Mahoko and Izumiya, Makoto and Haniu, Hisao and Ueda, Katsuya and Konishi, Kosuke and Ishida, Haruka and Kuroda, Chika and Uemura, Takeshi and Aoki, Kaoru and Matsuda, Yoshikazu and Saito, Naoto},
 issue = {7},
 journal = {NANOMATERIALS},
 month = {Jul},
 note = {One of the greatest challenges to overcome in the pursuit of the medical application of carbon nanomaterials (CNMs) is safety. Particularly, when considering the use of CNMs in drug delivery systems (DDSs), evaluation of safety at the accumulation site is an essential step. In this study, we evaluated the toxicity of carbon nanohorns (CNHs), which are potential DDSs, using human lymph node endothelial cells that have been reported to accumulate CNMs, as a comparison to fibrous, multi-walled carbon nanotubes (MWCNTs) and particulate carbon black (CB). The effect of different surface characteristics was also evaluated using two types of CNHs (untreated and oxidized). In the fibrous MWCNT, cell growth suppression, as well as expression of inflammatory cytokine genes was observed, as in previous reports. In contrast, no significant toxicity was observed for particulate CB and CNHs, which was different from the report of CB cytotoxicity in vascular endothelial cells. These results show that (1) lymph endothelial cells need to be tested separately from other endothelial cells for safety evaluation of nanomaterials, and (2) the potential of CNHs as DDSs., Article, NANOMATERIALS. 10(7):1374 (2020)},
 title = {Cellular Responses of Human Lymphatic Endothelial Cells to Carbon Nanomaterials},
 volume = {10},
 year = {2020}
}